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ABSTRACT
Amphiphilic block copolymers have been developed
recently for their efficient, in vivo transfection
activities in various tissues. Surprisingly, we
observed that amphiphilic block copolymers such
as Lutrol do not allow the transfection of cultured
cells in vitro, suggesting that the cell environment is
strongly involved in their mechanism of action. In an
in vitro model mimicking the in vivo situation we
showed that pre-treatment of cells with Lutrol,
prior to their incubation with DNA molecules in the
presence of cationic lipid, resulted in higher levels of
reporter gene expression. We also showed that this
improvement in transfection efficiency associated
with the presence of Lutrol was observed irre-
spective of the plasmid promoter. Considering the
various steps that could be improved by Lutrol,w e
concluded that the nucleic acids molecule internal-
ization step is the most important barrier affected by
Lutrol. Microscopic examination of transfected
cells pre-treated with Lutrol confirmed that more
plasmid DNA copies were internalized. Absence of
cationic lipid did not impair Lutrol-mediated DNA
internalization, but critically impaired endosomal
escape. Our results strongly suggest that in vivo,
Lutrol improves transfection by a physicochemical
mechanism, leading to cellular uptake enhancement
through a direct delivery into the cytoplasm, and not
via endosomal pathways.
INTRODUCTION
Gene transfer in cultured cells is, at present, in the vast
majority of cases achieved using cationic lipids or
polymers. However, despite having been widely used for
more than 10 years for in vitro transfection applications,
the use of these molecules has not yet been translated to
application in humans because of low in vivo transfection
efﬁciencies and toxicity issues. In this context, a new class
of non-viral vectors has emerged for in vivo gene delivery,
based on amphiphilic block copolymers consisting of
hydrophilic blocks of poly(ethylene oxide) (PEO) and
hydrophobic blocks of poly(propylene oxide) (PPO),
covalently linked together in various structures. Linear
non-ionic block copolymers form an A–B–A or B–A–B
tri-block structure of PEO–PPO–PEO or PPO–PEO–
PPO, whilst tetra-functionalized, slightly positively
charged block copolymers form an X-shaped structure
composed of four PEO–PPO moieties linked by the hydro-
phobic extremity to a central ethylenediamine core (1).
Linear and X-shaped block copolymers have been used
successfully to increase the deliver reporter and therapeut-
ic genes in various rodent organs including physiological
skeletal and cardiac muscle, lung and eyes (2–6) compared
to that achieved with the naked DNA approach pioneered
by Wolff and colleagues (7–9). Block copolymers have
also been used to deliver genes to express proteins of
local or systemic therapeutic interest in mouse models of
human pathologies including erythropoietin (EPO) to
treat anaemia in kidney failure or dystrophin in
Duchenne muscular dystrophy (DMD) (10,11). More
recently, an X-shaped block copolymer led to a dramatic
improvement in DNA vaccination for prophylactic and
therapeutic applications by reducing the amount of
injected DNA by a factor of at least 50. This rendered
the effective DNA dosage more compatible with human
use than that achieved with naked DNA, where high
amounts of DNA in the milligram range were injected,
with disappointing humoral and cellular responses.
Amphiphilic block copolymers used in these various
reports belong to a wide chemical family generated by
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and propylene oxide (PO) units, leading to polymers of
molecular weight ranging from 200 to 20000 g/mol and
of amphiphilic character measured by the hydrophilic/
lipophilic balance (HLB) ranging from 1 to 24, corres-
ponding to a percentage of PEO of 10 to 80%, respective-
ly. These polymers are also characterized by their critical
micellar concentration (CMC) and critical micellar tem-
perature (CMT). These factors govern the self-assembly of
these amphiphilic molecules in solution, with unimers
formed below the CMC and CMT and, above the CMC
and CMT, supramolecular structures including micelles
with a hydrophobic core of PPO blocks surrounded by a
hydrophilic corona of PEO and also lyotropic liquid
crystalline mesophases of varying morphology. The
physicochemical properties of block copolymers govern
not only the morphology of self-assembly, but also the
toxicity, which is inversely related to the percentage of
PEO present in the copolymer (12). By contrast, linear
PEO–PPO–PEO tri-block copolymers containing a high
percentage of PEO are approved by the FDA for intra-
venous, oral and topical administration. Linear and
X-shaped block copolymers, which have been reported
to deliver genes in vivo, usually have a molecular weight
below 15000g/mol, a percentage of OE ranging from
10 to 80% and are used at a dose ranging from 0.01 to
5% (w/w).
Some studies have been reported which have aimed to
understand the mechanism of action of this novel class of
non-viral vectors, at the physicochemical level, by
investigating the interaction between block copolymers
and DNA molecules, and at the physiological level by
studying their biological impact on cell physiology.
These studies showed that the physicochemical character-
ization of block copolymer/DNA complexes was not per-
formed easily with the same techniques that have been
used to describe the physicochemical properties of
complexes resulting from the interaction of DNA mol-
ecules with cationic lipids and polymers. This highlights
a difference in the way that DNA interacts with either
block copolymers, or highly-positively-charged cationic
lipids or polymers. Interactions of DNA with block co-
polymers probably occur mainly through hydrogen
bonding, hydrophobic and some ionic interactions, but
not via strong ionic interactions. On the contrary, strong
ionic interactions are observed to occur between DNA
and cationic lipids or polymers (13). It has also been
reported that block copolymers interact with lipidic ﬁlm,
leading to ionic permeabilization of the reconstituted
artiﬁcial membrane (14). More recently, it was reported
that a linear tri-block copolymer with 50% PEO acted as a
biological modiﬁer, activating the NFkB inﬂammation
cellular pathway leading to the enhancement of transfec-
tion efﬁciency by the recruitment of transcription factors
on the cytomegalovirus promoter, which was used to
control the transgene expression (15–17). In fact, we
showed previously that PE6400, composed of 40% PEO,
promoted DNA trafﬁcking into the nucleus and increases
gene expression when microinjected into the cell cyto-
plasm (4). Nevertheless, this mechanism for linear block
copolymer of a low PEO percentage, which is associated
with toxicity, does not necessarily apply to other linear
tri-block copolymers consisting of a higher PEO percent-
age which have been reported as non-toxic and efﬁcient
for gene transfer.
In this study, we report that Lutrol, a linear tri-block
copolymer with 80% PEO and a molecular weight of
8600g/mol, which has been reported to deliver therapeutic
genes in mouse models of human diseases with a very
good safety proﬁle (10), mediates the increase of cellular
internalization of DNA and siRNA molecules by a differ-
ent pathway to that used by cationic lipids or polymers.
The incapacity of lutrol to perform efﬁcient transfection in
cationic lipids-free in vitro cells strongly supports its in-
ability to perform endosomal escape, and strongly suggest
that Lutrol acts in vivo via an endocytosis-independent
internalization pathway. Our results obtained in vitro
revealed Lutrol general abilities concerning cell
membrane interactions that are certainly applicable to
its in vivo mechanism. We propose that 80% PEO linear
tri-block copolymers do not promote gene transfer by the
activation of inﬂammation cellular pathways, but rather
enhance cellular uptake of DNA molecules through a
facilitated plasma membrane transport.
MATERIALS AND METHODS
Plasmids, siRNA, amphiphilic block copolymers and
cationic vectors
pCMV-Luc (18) and Gwizz-Luc (Genlantis, San Diego,
CA) are plasmids encoding the luciferase reporter gene
under the control of the human cytomegalovirus
immediate-early gene promoter. pGL3 (Promega,
Madison, WI) is a plasmid encoding the luciferase
reporter gene under the control of the SV40
immediate-early gene promoter. pCMV-GFP (Clontech,
Palo Alto, CA) is a plasmid encoding green ﬂuorescent
protein reporter gene, under the control of the human
cytomegalovirus immediate-early gene promoter.
Plasmids were puriﬁed from recombinant Escherichia
coli by means of Endofree plasmid puriﬁcation columns
(Qiagen, Chatsworth, CA). Human anti-Lamin A/C
siRNA was obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). Negative control siRNA (AllStars
Negative Control, sense sequence: UUCUCCGAACGU
GUCACGU) was provided by Qiagen (Chatsworth, CA).
F38 [80% poly(ethyleneoxide), molecular weight (MW)
4700], F68 [80% poly(ethyleneoxide), MW 8400] and F108
[80% poly(ethyleneoxide), MW 14600] were generously
provided by BASF (Mount Olive, NJ). For in vitro experi-
ments, solutions of block copolymers were prepared at the
given weight-to-weight (w/w) concentration in high
glucose DMEM (Invitrogen) (4.5g/l) supplemented with
10% FBS, 2mM L-glutamine, 10mg/ml streptomycin,
100mg/ml penicillin. For in vivo experiments, stock solu-
tions of block copolymers were prepared at the given
weight-to-weight (w/w) in sterilized water. Solutions
were stored at 4C.
DOSP and BGTC were synthesized as previously
described (19–22) and provided by IN-CELL-ART
(Nantes, France). DOPE was obtained from Avanti
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Polyplus (Illkirch, France). ICAFectin 442 was obtained
from IN-CELL-ART (Nantes, France). DOSP/DOPE
(1/1, mol/mol) and BGTC/DOPE (2/3, mol/mol) cationic
liposomes were prepared as previously described (23).
In vivo plasmid DNA formulations and animal
experiments
Animal experiments were performed in accordance with
the guidelines of the French Institut National de la Sante ´
et de la Recherche Me ´ dicale. Eight-week-old female CD1
mice were obtained from Charles River (Chatillon-
sur-Chalaronne, L’Arbresle, France). At least ﬁve mice
were injected in each experimental group and each
experiment was repeated two times. For intramuscular
injections, mice were anaesthetized with Hypnomidate
(40mg/kg, intraperitoneal injection, Janssen-Cilag,
Issy-les-Moulineaux, France). Fifty microliters of block
copolymer/DNA formulations, cationic lipid/DNA
lipoplexes or naked DNA were injected into shaved
tibial anterior muscles at a single site, using a microﬁne
syringe (U100; Becton Dickinson, Rungis, France).
In vitro formulation
DNA lipoplexes were formulated at a positive charge ratio
of four with 1mg plasmid. Complexes of DNA with
cationic lipids were prepared by mixing equal volumes of
cationic lipids in water with plasmid at the desired con-
centration in 300mM NaCl. Complexes of siRNA
(37.5ng) with ICAFectin 442 were prepared as described
by the manufacturer. Hybrid DNA/siRNA lipoplexes
were formulated at a charge ratio of four with 500ng
DNA mixed with 500ng siRNA. Complexes of DNA-
siRNA with DOSP–DOPE were prepared by mixing
equal volumes of cationic lipids in water with nucleic
acids at the desired concentration in 300mM NaCl.
In cell conditions, lipoplexes were incubated at room
temperature for 15–20min before transfection.
Cell culture, block copolymer incubation and transfection
HeLa, mouse muscle C2C12, COS-7 green monkey kidney
ﬁbroblast and H1299 human lung cancer cells were grown
at 37Ci n5 %C O 2/humidiﬁed atmosphere in high glucose
DMEM medium (4.5g/l) supplemented with 2mM L-glu-
tamine, 10mg/ml streptomycin, 100mg/ml/ml penicillin
(GIBCO and Invitrogen Life Technologies, Carlsbad,
CA) and with 10% FBS (Eurobio, Courtaboeuf,
France). CHO and CHO-2241 heparan sulfate depleted
(CHO HS
) cells (a generous gift from P. Fender,
Grenoble, France) were grown in the same conditions,
replacing DMEM medium by Kaighn’s F12 medium
(GIBCO, Carlsbad, CA). One day before transfection,
cells were transferred into 24-well culture plates, at
60000 cells per well, resulting in 70–80% conﬂuence 24h
later. Two hours before transfection, cells were incubated
with block copolymers at the given w/w concentration in
DMEM serum-supplemented medium or Kaighn’s F12
serum-supplemented medium for CHO and CHO HS

cells, respectively. Transfection was performed by adding
50ml DNA complexes or siRNA/DNA complexes in
450ml serum-free medium or 107ml siRNA complexes in
500ml serum-free medium to each well. For CHO and
CHO HS
 transfection, 100ml lipoplex, complexed or
not with Lutrol, was added in 450ml serum-free
medium. After 2 h, the transfection medium was
replaced by 500ml fresh serum-supplemented medium.
Cells were cultured for an additional 20h before gene ex-
pression was determined. Transfection experiments were
performed in duplicate.
Luciferase and GFP assays
One day after transfection, cells were rinsed with 300ml
phosphate-buffered saline (PBS) and lysed with 300ml
reporter lysis buffer (Roche Diagnostics, Mannheim,
Germany) supplemented with a protease inhibitor
cocktail (Roche Diagnostics). Complete lysis was
assured by one freeze–thaw (80C/20C) cycle. Samples
were then centrifuged at 10000rpm for 5min at 4C.
Luciferase activity was measured using the Promega
Luciferase Assay system (Promega, Madison, WI).
Luciferase activity was measured from an aliquot of
supernatant with a VICTOR
2 multilabel counter (Perkin
Elmer, Les Ulis, France). Luciferase activity was assayed
by measuring light emission after addition of 100ml
luciferase substrate to 20ml supernatant. Luciferase
activity was normalized to the total protein concentration
of the sample. Protein content was measured with a BCA
protein assay kit (Pierce, Rockford, IL).
GFP ﬂuorescence measurements were performed on a
180ml aliquot of supernatant using a Victor2 apparatus
(PerkinElmer, Les Ulis, France). Fluorescence was
normalized to the total protein concentration of the
sample.
Flow cytometry experiments
Twenty hours after transfection, samples of cells (10
5–10
6)
were collected and re-suspended in PBS. The resulting cell
suspension was assayed for the expression of GFP by ﬂow
cytometer analysis using a FACScalibur ﬂow cytometer
(Becton Dickinson). The percentage of GFP-positive
cells was determined by the ﬂow cytometer programme.
Quantiﬁcation of YOYO-1 labelled plasmid internaliza-
tion was performed with luciferase encoding plasmid.
Plasmid was added to a solution of YOYO-1 (0.1mM)
in dimethyl sulfoxide (DMSO) at the dye/base pair
ratio 1/150. This mixture was incubated at room tempera-
ture for 10min before self assembly of DOSP/DOPE–
DNA lipoplexes at a DOSP–DNA charge ration of 4
(±). Then, HeLa cells were pre-incubated in the
presence or in the absence of 3% Lutrol for 1h before
transfection with labelled lipoplexes. Twenty four hours
post-transfection, cells were analyzed for their YOYO
ﬂuorescence content by ﬂow cytometer analysis as
described above.
Real-time, quantitative RT–PCR
Total RNA was extracted from transfected cells by
TRIzol treatment. Reverse transcription was performed
with total RNA using oligo(dT)20 primers and
SuperScript III reverse transcriptase (Invitrogen). The
1612 Nucleic Acids Research, 2011,Vol.39, No. 4expression of lamin A/C was quantiﬁed by real-time PCR
(ABI prism7000, Applied Biosystems, Foster City, CA).
Experiments were performed using PCR Master Mix
(Applied Biosystems) with 300nM each primer and
250nM TaqMan MGB probes. Primers were obtained
from Applied Biosystems. The cycling conditions
included a hot start at 95C for 10min, followed by 40
cycles at 95C for 15s and at 60C for 1min. Results were
normalized to the endogenous hypoxanthine-guanine
phosphoribosyltransferase (HPRT1) control gene and ex-
pressed according to the 2
CT method (24).
Labelling of lipoplexes
The labelling procedure of lipoplexes with 15nm aminated
gFe2O3@SiO2 nanoparticles (Nps) is described in detail
elsewhere (25). Brieﬂy, 3.6810
11 Nps and 0.5mg
pCMV-Luc were mixed at a ratio Np/pDNA of 5 (mole/
mole) in 300mM NaCl. Then an equal volume of cationic
liposome in pure water was added, to a ﬁnal lipoplex
charge ratio (±) of four. The formulation was prepared
in a 150ml ﬁnal volume for each well.
Conventional TEM
Cells were processed for ultramicrotomy according to
standard procedures. Brieﬂy, after trypsin treatment,
cells from eight wells were pooled, pelleted and ﬁxed for
2h in a mixture of 2.5% glutaraldehyde and 4%
paraformaldehyde in 0.2M cacodylate buffer (pH 7.4).
Sample pellets were then post-ﬁxed for 1h at 4C with
1% osmium tetroxide in the same buffer and were
dehydrated with ethanol before embedding in
Epon-Araldite. Thin sections (65nm thick) were stained
successively with 5% uranyl acetate and 1% lead citrate,
unless stated in the text. TEM observation was performed
with a FEI tecnai F20 operated at 200kV under low-dose
conditions.
Quantiﬁcation of labelled lipoplexes within cell sections
The measurement of Np areas was carried out on images
of unstained sections using image J software. Np densities
were selected after a manual threshold. The area corres-
ponding to these densities was determined with the
‘analyse particles’ function providing a surface of Nps.
To determine the area of cell sections, we drew the cell
contour manually and measured the area with the ‘analyse
particles’ function. The ratio of Np surface to cell section
surface allowed the estimation of the amount of Nps per
cell, considering that the 65nm cell section is in the order
of magnitude of Np size. This analysis was performed on
158 cell sections from 13 grid squares in total.
RESULTS
Amphiphilic block copolymers promote high gene transfer
in muscular cells in vivo but not in vitro
In order to assess the impact of the cell environment on
transfection efﬁciency, plasmid DNA either naked or
complexed either with Lutrol, an amphiphilic block co-
polymer of 80% PEO, or with cationic liposomes of
DOSP/DOPE, was injected into mouse tibial anterior
muscle (Figure 1) or incubated, in vitro, with C2C12
mouse muscle cells (Figure 1). Luciferase reporter gene
expression in C2C12 and in tibial anterior muscle was
evaluated 24h and 7 days after transfection, respectively.
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Figure 1. In vivo and in vitro transfection efﬁciency of amphiphilic block copolymers, cationic lipids and naked DNA. A luciferase gene expression
assay was performed to compare the transfection efﬁciencies of an amphiphilic block copolymer, Lutrol and cationic liposomes of DOSP–DOPE,
either in vivo in mouse tibial anterior muscle 7 days after transfection (black bars) or in vitro in the C2C12 mouse muscle cell line 24h after
transfection (white bars). The luciferase gene-encoding plasmid was either naked or complexed with 3% Lutrol or with DOSP–DOPE at a charge
ratio of ±4. The amount of plasmid transfected in vitro and in vivo was, respectively, 1 and 10mg.
Nucleic Acids Research,2011, Vol.39, No. 4 1613Injection of 10mg plasmid DNA complexed with 3%
Lutrol led to high luciferase expression in mouse tibial
anterior muscle, compared with the very low luciferase
expression achieved with naked DNA or DOSP/DOPE–
DNA lipoplexes. By contrast, transfection of cultured
C2C12 with 1mg of pCMV-Luciferase complexed with
Lutrol did not allow luciferase expression, whereas
cationic liposomes of DOSP/DOPE led to a dramatic
increase in luciferase expression. These results strongly
suggest that the cell environment plays an important
role in amphiphilic block copolymer and cationic
liposome transfection efﬁciency.
Lutrol and other 80% PEO amphiphilic block
copolymers promote efﬁcient muscular gene transfer
irrespective of the plasmid promoter
Next, we investigated a possible role of amphiphilic block
copolymers with the 80% PEO used in this study, in the
activation of some transcription factors, as has been pre-
viously described for block copolymers containing 50%
PEO (15,16). For this purpose, we compared transfection
efﬁciencies in tibial anterior muscle using two different
plasmids encoding luciferase, controlled either by the
CMV or SV40 promoter. These two promoters contain
different transcription factor binding sites (Table 1). The
three polymers tested were all composed of 80% PEO but
with various molecular weights, ranging from 4700 to
14700 Da. Figure 2 shows that similar luciferase expres-
sion was obtained after intramuscular injection of both
plasmids complexed with the various block copolymers.
These data suggest that the mechanism of action of
amphiphilic block copolymers of 80% PEO does not
depend on the activation of speciﬁc transcription factors,
unlike that of 50% PEO copolymers.
In vitro model to study the in vivo mechanism of
amphiphilic block copolymers
As studying the mechanism of action of block copolymers
in vivo is very difﬁcult, we decided to set up an in vitro
model allowing variation of several parameters, to
understand how block copolymers dramatically increased
gene expression in vivo. To this end, since block copoly-
mers as naked DNA alone did not transfect cells in vitro,
we studied the inﬂuence of block copolymers on reporter
gene expression by ﬁrst treating cultured cells with the
optimized in vivo concentration of block copolymers
before the addition of DNA molecules complexed with
cationic vectors.
C2C12 cells were pre-treated with Lutrol and then
transfected with 1mg plasmid DNA encoding luciferase
complexed with DOSP/DOPE at a charge ratio of four
(±). Pre-treatment with 3% Lutrol led to the enhance-
ment of luciferase expression in C2C12 transfected cells
compared with untreated cells (Figure 3A). Cell treatment
with Lutrol during 0.5 to 2h before transfection, at
various concentrations ranging from 0.5 to 3% led to a
similar enhancement of transfection efﬁciency (data not
shown). Of note the same optimal Lutrol concentration
was observed both in vitro and in vivo. This improvement
in transfection efﬁciency was also observed with a plasmid
encoding another reporter gene; i.e. GFP (Figure 3A).
Pre-treatment with Lutrol of various cell lines, including
COS-7, C2C12, HeLa and H1299 cells, also led to a
similar enhancement of transfection efﬁciency
(Figure 3B). Various types of cationic lipids were also
used and led to the same increase in reporter gene
activity after pre-treatment with Lutrol (Figure 3C).
Transfection of H1299 cells with JetPEI was also
enhanced by pre-treatment with Lutrol (Figure 3D).
No toxicity was detected in the in vitro model as assessed
by MTT experiments (Supplementary Figure S1) and by
analysis of NFkB and P53 transcription activation
(Supplementary Figure S2).
Altogether, these data suggest that the enhancement of
transgene expression mediated by pre-treatment with
Lutrol did not depend on neither the reporter gene, the
cell line, nor the cationic vector used.
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Figure 2. Plasmid promoter inﬂuence on transfection efﬁciency of
block copolymers in mouse tibial anterior muscle as a function of the
block copolymer molecular weight. Shaved tibial anterior muscles of
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Table 1. Transcription factor binding sites in the CMV and SV40
promoters [based on Promega data (15)]
Transcription factor binding sites CMV
Promotor
SV40
Promotor
Octamer-binding factor1 ++
Activator protein 1 (AP1) ++
Zinc ﬁnger-containing protein SP1 ++
NF-E2 p45  +
GC box elements  +
CRE-binding protein 1/c-Jun heterodimer + 
cAMP-responsive element binding protein + 
NFkB + 
c-Rel + 
AvianC-type LTR TATA box + 
Cellular and viral TATA box elements + 
E4BP4, bZIP domain, transcription repressor + 
Activating transcription factor + 
1614 Nucleic Acids Research, 2011,Vol.39, No. 4Amphiphilic block copolymers enhanced in vitro transgene
expression, irrespective of their molecular weight and the
plasmid promoter
Next, in order to validate our in vitro model and to
provide an insight into the in vivo mechanism of action
of block copolymers, we investigated the inﬂuence of the
plasmid DNA promoter and the molecular weight of the
block copolymer on transfection efﬁciency in cultured
cells. Figure 4 shows that, as observed in vivo (Figure 2),
pre-treatment of cultured cells with block copolymers of
various molecular weights led to a similar increase in
luciferase expression (Figure 4A). We also showed that
either CMV or SV40 promoters led to similar reporter
gene expression enhancement in cells pre-treated or not
with Lutrol (Figure 4B). These data strongly suggest
that, as observed in vivo, Lutrol and other 80% PEO
block copolymers did not activate promoter-speciﬁc tran-
scription factor signalling pathways, but increased gene
expression by another mechanism.
Lutrol enhanced DNA cellular transport and not reporter
gene expression
To investigate a possible role of amphiphilic block
copolymers in the stimulation of transcription and
translation, cells were treated with Lutrol after the intra-
cellular internalization of DNA molecules had occurred.
Figure 5A shows that enhancement of luciferase expression
was observed only when cells were pre-treated with
Lutrol, suggesting that Lutrol did not promote
reporter gene expression stimulation at the transcription
or translation level, but rather stimulated steps involved
in DNA internalization, endosomal escape or nuclear
targeting.
To strengthen this hypothesis, we studied the inﬂuence
of temperature on luciferase expression obtained after
pre-treatment of cells with Lutrol. As expected, in the
absence of pre-treatment with Lutrol, we observed that
cationic lipid-mediated transfection was partially inhibited
at 4C. By contrast, transfection enhancement by Lutrol
was not affected by the transfection temperature, suggest-
ing that the main mechanism of block copolymers is
probably due to the improvement of the different steps
involved in DNA transfection by a physicochemical
process (Figure 5B).
Did Lutrol increase cytoplasmic or nuclear delivery?
To analyse the contributions of endosomal escape and
nuclear import in the enhancement of transgene expres-
sion after cell pre-treatment with Lutrol, we studied the
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Figure 3. Effect of amphiphilic block copolymers on in vitro transfection efﬁciency, as a function of (A) the reporter gene, (B) the cell line, (C) the
cationic lipid and (D) the chemical structure of the cationic vector. Reporter gene expression assay was performed in transfected cells after Lutrol
treatment (gray bars) or without Lutrol treatment (white bars). Treated cells were incubated with Lutrol diluted at optimized concentration
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Nucleic Acids Research,2011, Vol.39, No. 4 1615inﬂuence of cell pre-treatment with Lutrol on gene
silencing efﬁciency (Figure 6). Indeed, gene silencing
occurs after the delivery of siRNA in the cell cytoplasm
and not in the nucleus. Thus, if Lutrol pre-treatment
increases nuclear import of the transfected nucleic acids,
efﬁciency of gene silencing, i.e. the residual lamin A/C
expression would not be modiﬁed by Lutrol. On the
contrary, if nuclear import is not the limiting step
overcome by Lutrol, but rather the common steps of
plasmid and siRNA transfection, i.e. cellular internaliza-
tion or endosomal escape, Lamin A/C inhibition would
also be enhanced by Lutrol pre-treatment. H1299 cells
were pre-treated with Lutrol and then transfected with
anti-lamin A/C siRNA complexed with ICAFectin 442
Reagent, in conditions that partially inhibited lamin A/C
expression. In the absence of Lutrol pre-treatment,
RT–PCR results showed that the percentage of lamin A/
C inhibition was 31%, whereas Lutrol pre-treatment led
to a percentage of inhibition of 58%, supporting the
notion that Lutrol also enhanced the siRNA transfection
process. Next, we decided to study in a single experiment
the effect of Lutrol pre-treatment on both siRNA and
DNA transfection using particles similar to the one used
for plasmid DNA experiments. In this condition using
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1616 Nucleic Acids Research, 2011,Vol.39, No. 4mixed particles would allow us to compare Lutrol impact
on gene silencing and reporter gene expression using a
single particle containing DNA and siRNA molecules.
To this purpose, 500ng siRNA were mixed with 500ng
plasmid DNA to obtain a total dose of 1mg nucleic acids,
complexed with DOSP/DOPE at a charge ratio of four
(±). H1299 cells were pre-treated with Lutrol and then
transfected with hybrid siRNA/DNA particles. The results
showed that anti-lamin siRNA transfection allowed an
inhibition of lamin RNA expression of 18% and, most
importantly, Lutrol pre-treatment increased this inhib-
ition to 41%. We also observed that luciferase expression
was enhanced by Lutrol pre-treatment (data not shown).
These data strongly suggest that Lutrol enhanced the
common steps of plasmid DNA and siRNA transfection,
i.e. cellular internalization and endosomal escape, and did
not enhance the terminal steps of plasmid transfection,
including nuclear import, transcription and translation.
Did Lutrol increase the transfected cell number?
To conﬁrm that block copolymers enhance transfection by
DNA molecule internalization and/or endosomal escape,
we measured the percentage of transfected cells by FACS
analysis using plasmid DNA encoding GFP. FACS
analysis showed a similar percentage of GFP-expressing
cells in the presence or absence of Lutrol pre-treatment
(Figure 7). As a control, luciferase expression was strongly
enhanced after pre-treatment with Lutrol during the
same experiment (Figure 7). These results were also in
good agreement with the experiment using b-galactosidase
as a reporter gene, as shown by the presence of the same
number of blue cells (data not shown) irrespective of
pre-treatment with Lutrol. However, in these two experi-
ments, we noticed that cells pre-treated with Lutrol
expressed the reporter gene at a higher level, as shown
by the blue intensity of the cells (data not shown).
The same observation was made in GFP-transfected
cells pre-treated with Lutrol (data not shown). These
results strongly suggest that, even if the same number of
cells were transfected in the presence of Lutrol, the
number of plasmids entering each cell would certainly be
increased.
Lutrol enhanced DNA cellular uptake: lipoplex labelling
and TEM imaging
Next, we investigated if the transfection enhancement
observed after lutrol pre-treatment was associated with
an increase in lipoplex internalization. In order to detect
DNA cellular uptake by TEM, lipoplexes were labelled
with NPs. Cells were incubated for 2h in the presence of
labelled lipoplexes and then submitted to a ﬁxation pro-
cedure. Labelled lipoplexes were observed in both
untreated and treated cells and possessed similar morpho-
logical aspects indicating that Lutrol treatment did not
modify lipoplex structure (Figures 8C and F). To quantify
the cellular uptake of lipoplexes in both conditions, we
estimated the Np amount per cell by measuring the Np
surface per cell surface (see ‘Materials and methods’
section). The analysis was performed on 158 cell sections
from 13 grid squares. Our quantitative analysis revealed
an increase of DOSP-lipoplex uptake by treated cells, as
shown in Figure 8E and I. This result suggests that
Lutrol promoted an enhanced DNA internalization
through the cell membrane. As a control, cells transfected
with labelled and unlabelled lipoplexes showed similar
luciferase activities (data not shown). Moreover, a
strong transfection enhancement after cell treatment
with Lutrol was also observed with labelled lipoplexes
(data not shown), indicating that Nps did not inﬂuence
transfection efﬁciency, conﬁrming ﬁndings of Le Bihan
(25). In addition, for both untreated and treated cells,
we also determined that the surface of cells containing
Nps represented 30% of the total area of cells, which cor-
responds to the percentage of transfected cells as indicated
by FACS analysis and microscopy on GFP transfected
cells. We also analysed the lipoplexes internalization by
means of YOYO-1-labelled DNA. Flow cytometry
analysis showed that cells pre-treated with Lutrol
exhibit a 2-fold increase in ﬂuorescence intensity compare
to cells that were not pre-incubated with Lutrol
(Figure 9). Altogether, these results indicated clearly that
Lutrol enhanced the cellular uptake of nucleic acids.
Lutrol promoted DNA interaction with cell membranes
As efﬁcient, cationic vector-mediated transfection requires
the condensation of DNA in positively charged particles,
it has been inferred that anionic proteoglycans are poten-
tial receptors (26). Direct evidence for the involvement of
heparan sulfate proteoglycans (HSPGs) in transfection
has been obtained by several groups (27,28). Figure 10
shows clearly that transfection of heparan sulfate-deﬁcient
CHO (CHO HS
) cells by DOSP/DOPE–DNA lipoplexes
was strongly decreased compared with that obtained in
normal CHO cells. By contrast, CHO HS
 transfected
by lipoplexes in the presence of Lutrol exhibited an
enhanced luciferase expression. These data strongly
0
5
10
15
20
25
30
0
5
10
15
20
25
30
35
-+-+
L
u
c
i
f
e
r
a
s
e
 
(
n
g
 
/
 
m
g
 
p
r
o
t
e
i
n
)
G
F
P
 
E
x
p
r
e
s
s
i
n
g
 
C
e
l
l
s
 
(
%
)
Lutrol®pretreatment
590 836
Mean cell 
fluorescence intensity
Figure 7. Effect of block copolymers on the percentage of transfected
cells. C2C12 cells were transfected after Lutrol treatment (gray bars)
or without Lutrol treatment (white bars). Treated cells were incubated
with Lutrol diluted at optimized concentration in culture medium for
2h before transfection. Onemg of GFP or luciferase encoding plasmid
was complexed with DOSP/DOPE at a charge ratio of ±4.GFP
expressing cells were counted by ﬂow cytometry and a luciferase gene
expression assay was performed 24h after transfection.
Nucleic Acids Research,2011, Vol.39, No. 4 1617Figure 8. TEM visualization of H1299 cells cellular uptake of DOSP–DOPE/plasmid/Nps (A–C) and after a Lutrol treatment (D–F) observed 2h
after transfection. Cells were transfected with luciferase encoding plasmid complexed with Nps (1/5) and with DOSP–DOPE at a charge ratio of ±4.
Ultrathin sections were observed at low (A, D), medium (B, E) and high (C, F) magniﬁcation and revealed the presence of labelled lipoplexes
containing electron-dense Nps (black arrows). Cell sections were screened for the presence of Nps (asterisks in A and D). Labelled lipoplexes were
observed within the cytoplasm and formed multilamellar assemblies (C, F enlargement of marked areas with black squares in B and E). The
measurement of Np amount per cell section was performed on unstained sections (G) and analysed after threshold (H). The result is expressed
as the ratio of Np surface per cell surface. This ratio increased after Lutrol treatment (I). Scale bars are 10mm (A, D) 500nm (B, E) and 50nm
(C, F). Nu Nucleus, M Mitochondria. The analysis was performed on 158 cell sections from 13 grid squares.
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cells (CHO HS
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1618 Nucleic Acids Research, 2011,Vol.39, No. 4suggest that Lutrol enhanced the interaction of DNA
particles with the cell membrane, improving their uptake.
Lutrol promoted DNA internalization but not endosomal
escape in vitro
To study whether Lutrol allows DNA internalization in
cultured cells without cationic lipids, we labelled DNA
molecules with NPs and observed cell section by TEM.
Thus, H1299 cells were incubated with labelled DNA
complexed with Lutrol. After 3h cells were ﬁxed and
submitted to the resin embedding method. TEM visualiza-
tion of cell sections shows that labelled DNA
was localized inside endosomal/lysosomal vesicles
(Figure 11C and D) but not in the cell cytoplasm. TEM
visualization was repeated 24h after transfection
and never revealed free DNA molecules in the cell cyto-
plasm (data not shown). However, as presented in the
companion paper (25) labelled DNA molecules could be
observed in the cell cytoplasm only in the presence of
cationic lipids. Of note, identical observations were
made on two different cells lines (data not shown).
These results strongly suggest that Lutrol acts as an
enhancer of nucleic acids cell-entry in vitro as well as
in vivo. The incapacity of Lutrol to perform efﬁcient
transfection in cationic lipids-free in vitro cells strongly
support its inability to perform endosomal escape, and
strongly suggest that Lutrol acts in vivo via an
endocytosis-independent internalization pathway.
DISCUSSION
Amphiphilic block copolymers consisting of EO and PO
represent a novel class of non-viral vectors for in vivo
nucleic acid transfer into various organs. Indeed,
numerous studies have shown clearly that in vivo injection
of DNA complexed with various linear non-ionic block
copolymers including Lutrol and PE6400, or tetra-
functionalized X-shaped block copolymers, leads to a
dramatic increase in transgene expression, using either a
reporter or therapeutic gene, in skeletal and cardiac
muscle and in lung, as well as in the corresponding patho-
logical tissues such as DMD muscles and cystic ﬁbrosis
lungs (4,6,11,29). Proof of the effectiveness of PEO/
PPO-based formulations was also reported previously by
Lemieux et al., who described the mixture of L61 and
F127—named SP1017—for the transfection of skeletal
muscle (2). More-recently, P85 was also reported to
increase transfection in muscle successfully (15), and
F68/DNA formulations were shown to efﬁciently transfect
eyes by drop delivery (3). Despite the great interest of
these block copolymers when applying gene transfer
in vivo setting, their mechanism of action is still ill
deﬁned. Even if it is tempting to assume that needle play
a role in DNA transfection in the muscle since muscle cells
form a speciﬁc anasthamosis cell tissue network, this
hypothesis cannot be applied to the mechanism of action
of the used block copolymers. Indeed, we also described
the large improvement of block copolymer over naked
DNA in other organs including heart and most import-
antly lungs (6) where the injection is performed without
needle, just by microspraying the solution containing
polymer/DNA complexes. Therefore, even if we cannot
deﬁnitively rule out that needle could play a role in
muscle transfection, it is likely that block copolymers mol-
ecules could also act by themselves as vectors improving
the in vivo internalization process of DNA molecules.
In the present study, we aimed to elucidate the precise
mechanism underlying amphiphilic block copolymer
transfection efﬁciency, which would facilitate an under-
standing of the differences in transfection abilities
in vitro and in vivo. In vivo, cells have at their disposal a
vascular system that brings them essential nutrients, whilst
highly dividing cell lines in vitro need to develop a strong
endocytotic activity to internalize culture medium nutri-
ents to sustain their rapid growth. This particular behav-
iour of in vitro cell lines leads to the facile, non-speciﬁc
internalization of DNA/cationic lipid or polymer
complexes. The cationic vectors currently used—cationic
lipids or cationic polymers—complex DNA to form stable
and positively charged particles, which interact
Figure 11. TEM visualization of H1299 cells cellular uptake of Lutrol/labelled-NpDNA observed 3h after incubation. Cells were transfected
with luciferase plasmid complexed with Nps (1/5) and with Lutrol at 3%. Ultrathin sections were observed at low (A), medium (B) and high
(C and D) magniﬁcation and revealed the presence of labelled complexes containing electron-dense Nps (black points). Labelled DNA were observed
within endosomal/lysosomal structures (C and D). Scale bar represents 1mm, 500 and 100nm in A, B and C–D respectively.
Nucleic Acids Research,2011, Vol.39, No. 4 1619electrostatically with negatively charged molecules such as
proteoglycans present at the surface of plasma mem-
branes, and are internalized by adsorptive endocytosis.
DNA molecules, then, escape from the endosomes by
mechanisms which have been proposed to be dependant
of the cationic vector used. Cationic lipids would promote
endosomal membrane disruption by a ‘ﬂip–ﬂop’ mechan-
ism, as has been proposed by Xu and Szoka (30). Cationic
polymers such as poly(ethylenimine) (PEI) would promote
endosome escape by over-acidiﬁcation, ultimately leading
to rupture of endosome membranes by a proton sponge
mechanism (31). After endosomal escape, DNA molecules
present in the cell cytoplasm reach the nucleus to be
transcribed and translated.
In order to attempt to understand the in vivo mechanism
of action of amphiphilic block copolymers, we designed an
in vitro model that consisted of treating cultured cells with
various amphiphilic block copolymers of different molecu-
lar weights, but with a constant percentage of EO. After
incubation with block copolymers, DNA molecules were
added with a cationic lipid to ensure efﬁcient endosomal
escape, one of the main barriers to transfection. We chose
the amphiphilic block copolymer subfamily of 80% PEO
because of its high in vivo transfection efﬁciency and good
tolerance (10,12). We showed by electron microscopy
studies and ﬂow cytometry analysis that cell pre-treatment
with Lutrol dramatically increased DNA molecule in-
ternalization into each transfected cell, subsequently
leading to an overall increase in transgene expression for
a constant percentage of transfected cells. Lutrol allowed
enhancing transfection efﬁciency for concentration lower
than 5%, corresponding also to the efﬁcient in vivo con-
centration dose. As increasing concentration of amphi-
philic block copolymers leads to the formation of
micelles, transfection enhancement is probably related to
the presence of unimers in vivo as well as in vitro.
Interestingly, toxicity assays showed that optimized
Lutrol concentration do not affect cell survival in vitro,
conﬁrming its in vivo good tolerance. In addition the
observed transfection enhancement was not restricted to
DNA molecules, as lower molecular weight nucleic acids
displaying the A conformation, such as siRNA, also led to
a better gene expression inhibition in Lutrol pre-treated
cells. These results strongly support a role of Lutrol in
the enhancement of the common step of DNA and siRNA
transfection, which is cellular internalization, and not in
the processes of intracellular trafﬁcking or transcription
and translation, as siRNA has to be located in the cyto-
plasm and DNA in the nucleus in order to be active.
This is in contrast with the report of Yang et al. (15),
using P85 [poly(ethyleneoxide)26-poly(propyleneoxide)40-
poly(ethyleneoxide)26] containing 50% PEO, which
activated the NFkB signalling pathway and promoted
DNA transfection in a promoter-dependant manner
after intramuscular injection. Indeed, it has been
proposed that P85 allows transfection of plasmids with
viral promoters containing binding sites for speciﬁc tran-
scription factors such as NFkB by the improvement of
plasmid nuclear targeting due to the NLS sequences
present within the transcription factors bound to the
plasmid promoter (15). This signalling pathway activation
mechanism was also described by Sriadibhatla et al., who
demonstrated that P85 activates in vitro luciferase tran-
scription in engineered cells expressing luciferase (17).
More recently, Yang et al. showed that P85 cell pre-
treatment also promotes transfection enhancement in a
promoter-dependant manner, suggesting a signalling
pathway activation-dependent mechanism (32). A
previous study with PE6400 containing 40% PEO also
showed that microinjected DNA molecules complexed
with PE6400 in the cell cytoplasm led to an increase in
transfection efﬁciency (4). This was probably due to the
activation of inﬂammation pathways resulting in the
binding of transcription factors to the CMV promoter,
as described with P85.
By contrast, the present study shows that block copoly-
mers of 80% PEO enhance DNA cell internalization
without displaying any promoter dependence, either
in vivo or in vitro. Transcription factor binding elements
present on CMV and SV40 promoters did not inﬂuence
the transfection efﬁciency, underlying the absence of
promoter-speciﬁc signalling pathway stimulation,
notably inﬂammatory such as NFkB signaling pathways.
Of note, Q-PCR experiments did not reveal any NFkB
transcript enhancement in Lutrol pre-treated cells,
contrary to what has been described with more hydropho-
bic block copolymers. Therefore, the present study
strongly suggests that these 80% PEO block copolymers
promote nucleic acid internalization without the activa-
tion of previously described inﬂammatory signalling
pathways highlighting their use for the expression of
protein of therapeutic interest, as we previously described
with EPO expression by intramuscular EPO gene transfer
which lasted for at least 250 days (10), and with dystroph-
in expression in mdx mice (11).
Previous results, and those obtained in this study, have
allowed us to propose the in vivo mechanism of action of
these 80% PEO block copolymers. Block copolymers
interacting with DNA molecules would not only enhance
the tissue distribution of DNA molecules, but also their
cellular internalization by a passive physicochemical
mechanism that does not involve an endocytotic process,
but rather by a direct delivery to the cytoplasm by fusion
with the cell membrane. Indeed, if DNA was internalized
via an endocytic pathway in vivo, PEO–PPO–PEO block
copolymers would be unable to facilitate endosomal
escape, as shown by the absence of free DNA molecules
in the cell cytoplasm as seen by TEM and efﬁcient trans-
fection in cultured cell lines. Thus, one can imagine that
Lutrol could favour the transmembrane passage of DNA
molecules, because it has been shown that, on the one
hand, polymers are able to interact with cell membranes
by their PPO hydrophobic moiety (33), and on the other
hand, polymers are also able to directly interact with
DNA by their PPO blocks (13). This explanation is also
supported by results described in this paper using heparan
sulfate-depleted CHO cells, where transfection of cationic
lipid/DNA lipoplexes was only observed in the presence of
Lutrol, whereas as clearly demonstrated by Kopatz et al.,
cation-mediated transfection requires heparan sulfate pro-
teoglycan (28). In addition, fusion process has already
been described in vitro by using negatively charged
1620 Nucleic Acids Research, 2011,Vol.39, No. 4lipoplexes (34). In the reported study, Resina and col-
leagues demonstrated that cationic but also anionic
lipoplexes are both internalized, but that only cationic
objects enter cells through temperature-dependant endo-
cytosis. Indeed, anionic objects were able to enter the cell
in a temperature-independent manner. Moreover, Lu et al.
also recently showed that siRNA lipid based carriers
mostly enter the cell through endocytosis-dependent
pathway (95%), but also through a minority
endocytosis-independent process, which was probably
achieved by fusion processes. Interestingly, they
observed that this minority endocytosis-independent
uptake was responsible of most of the silencing effect,
underlying the importance of endosomal sequestration
(35). In the present study, the passive enhancement
observed with Lutrol may be attributed to the
enhanced attachment of nucleic acids to cell membrane,
which could lead to an enhanced internalization through
endocytosis in in vitro conditions, but may also be
attributed to an enhanced fusion process. In the light of
these observations, fusion processes might make sense to a
passive and endocytosis-independent role of Lutrol
during in vivo transfection.
All together, these results show that all block copoly-
mers cannot be considered to have a common mechanism
of action regarding gene delivery but, depending on their
physicochemical characteristics, they can promote gene
expression either by direct fusion with the plasma
membrane, or by acting as a biological modiﬁer.
CONCLUSION
In vitro cells present a particular behaviour respective to
in vivo cells. In fact, as they do not have at their disposal a
vascular system to bring them the essential nutrients, they
developed an enhanced endocytosis to catch the nutrients
present in the medium. This extended endocytosis process
is the main route used by cationic vectors such as
lipoplexes and polyplexes to enter the cell. Their ability
to escape from endosomal sequestration (through ﬂip-ﬂop
or proton sponge mechanisms) ensures an efﬁcient gene
transfer in vitro. A contrario, non-ionic vectors such as
amphiphilic block copolymers like Lutrol can not
promote endosomal disruption, leading to lysosomal deg-
radation of the carried nucleic acid molecules. This lack of
endosomal escape ability allowed us to propose an in vivo
mechanism of internalization through an endocytosis
independant pathway. In fact, reductio ad absurdum,i f
Lutrol was internalized in vivo through endocytosis, its
inability to escape from endosomes could not lead to any
transfection signal. We support (i) that amphiphilic block
copolymers act in vivo independently of an endocytosis
mechanism, but also (ii) that they do not enhance
nucleic acid transfection at the same level. In fact, we
showed here that high HLB polymers, such as Lutrol,
facilitate the ﬁrst step of transfection, i.e. nucleic acid dif-
fusion and cell membrane interaction. Low and intermedi-
ate HLB polymers such as P85 have been shown to
enhance in vivo transfection through gene expression
stimulation and nuclear import facilitation by activating
inﬂammatory signalling pathways (15,16,17,32). This clas-
siﬁcation is in good agreement with previous data
obtained by Batrakova et al. concerning polymers struc-
ture inﬂuence on membrane interaction behaviour and
signalling pathways activation (33). Moreover, this
rational analysis of the different transfection steps
stimulated by these three vectors (high HLB polymers,
low HLB polymers and cationic lipids) could explain the
enhanced effect promoted by their combination as
demonstrated with SP1017 polymeric formulation (2) or
with multimodular lipid-polymer based systems (36). The
identiﬁcation of the mechanism of action of this novel
class of vectors for in vivo gene delivery should aid in
guiding the future design and synthesis of new block
copolymers.
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